Logo

Bayer Buys Sample-Prep System From Hamilton to Develop IVD Platform

Jul 31, 2006
NEW YORK (GenomeWeb News) - Bayer Healthcare today said it will buy a customized Microlab STARlet sample-preparation system from Hamilton Company as part of its plan to develop a new platform for performing molecular diagnostics.
 
The two companies will work together to customize the platform to meet the requirements of Bayer’s quantitative PCR technology.
 
Financial terms of the deal were not disclosed.

Filed under

Clinical Sequencing
Sequencing
Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.